Ranitidine · RANITIDINE 15 mg/mL · Syrup · Oral · Pharmaceutical Associates, Inc.
NDC 00121-0727-16 · 473 mL in 1 BOTTLE · ANDA · View full market →
Only one company currently supplies this market — there is no backup if it stumbles. The price has jumped 170% in a year, to $0.0579 per unit — sharp rises like this often mean supply is already tightening.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Pharmaceutical Associates, Inc. | RANITIDINE 15 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Ranitidine — NDC 00121-0727-16," retrieved September 3, 2026, https://drugdashboards.com/drug/00121072716.
Free to cite with attribution — see how the data is put together.